作者: Ainhoa Letamendia , Celia Quevedo , Izaskun Ibarbia , Juan M. Virto , Olaia Holgado
DOI: 10.1371/JOURNAL.PONE.0036690
关键词:
摘要: The zebrafish is a vertebrate model compatible with the paradigms of drug discovery. small size and transparency embryos make them amenable for automation necessary in high-throughput screenings. We have developed an automated platform vivo chemical screenings on that includes methods embryo dispensation, compound delivery, incubation, imaging analysis results. At present, two different assays to detect cardiotoxic compounds angiogenesis inhibitors can be automatically run platform, showing versatility system. A validation these known positive negative compounds, as well screening detection unknown anti-angiogenic been successfully carried out system developed. present totally allows organism.